CEO Dr Mohamed Ezani says organisations must first invest in preparing their people for AI, with leadership training critical to successful implementation.

Neil Patel, head of ventures at Redesign Health, discusses the rise in mergers and acquisitions across the digital health landscape in 2026 and the market forces driving companies and investors toward greater industry consolidation.

Dr. Daniel Ting, director of the SingHealth AI Office, shares how moving beyond siloed diagnostic tools to ambient AI allows clinicians to focus on history-taking and patient rapport over computer screens.

Neil Patel, head of ventures at Redesign Health, discusses the current digital health landscape, how investment has evolved since the COVID-19 pandemic and what investors look for when evaluating the next generation of healthcare companies.

Assort Health's Imaad Rashied says the company's platform unites interconnected workflows such as intake, referrals, outreach and payments to treat ambulatory care as one continuous journey.

Zaw Thet, cofounder and CEO of Exer AI, explains how the company uses computer vision and everyday device cameras, such as an iPad camera, to analyze human movement and provide clinicians with objective data to assess patients’ mobility.

HIMSS President and CEO Hal Wolf explains why a new AI Outcomes Framework is needed to evaluate the real-world impact of AI deployments.

Kevin Ritter, Altera Digital Health's CareInMotion EVP, explains why more connectivity doesn't always translate to sustainable rural outcomes. He says focusing on clinical data access is more likely to improve the value of interoperability funding.